Use of autoantibodies in breast cancer screening and diagnosis.
about
Molecular recognition of gangliosides and their potential for cancer immunotherapiesMolecular serum portraits in patients with primary breast cancer predict the development of distant metastasesSerum autoantibody measurement for the detection of hepatocellular carcinomaChemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancerClassifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigensSerum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients.Anti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinomaSerologic laboratory findings in malignancy.Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer.Recognition of tumor antigens in 4T1 cells by natural IgM from three strains of mice with different susceptibilities to spontaneous breast cancer.Biomarkers in the diagnosis of primary and recurrent breast cancer.Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.Spontaneous immunogenicity of ribosomal P0 protein in patients with benign and malignant breast lesions and delay of mammary tumor growth in P0-vaccinated mice.Osteopontin is a tumor autoantigen in prostate cancer patients.Early detection of lung cancer by using an autoantibody panel in Chinese population.
P2860
Q26830588-6BAD7CCF-3245-467E-A015-35856A2B727AQ30503693-554C9872-F14E-4CFC-B27B-F1F8FE674928Q34004797-278DE484-3F49-4798-A874-C6680F86AC5FQ34849073-03BBC0F7-A3D7-472F-9D21-B4D4C572A2D4Q35123700-96632EB3-4E04-4E47-9814-0F6CD16DF614Q35919544-0BA02C5B-0B37-4698-8DD8-A5A00A3E9BF8Q36410563-F5911C4C-FBEB-4948-9C7B-9B901C76F58DQ37212230-BBC60674-7A77-4D32-B31E-A33B4E7050FBQ37401677-2DA37649-84A9-46CE-AA4D-5E8DC0A76478Q37402807-86B4725F-CB31-4A80-B652-8DA51EA48124Q37594036-4C7F8EE1-2EBE-4462-90A1-59FA1853F1FDQ38052925-85316056-EAAA-4F9C-AFBD-C717FF841708Q38848896-4029194F-5D3F-48E7-8AE0-AA739912A19EQ39617426-443C2E5B-E08B-4CFD-AF23-455B0F476B5EQ41810965-CE6F6B86-8DE6-46C6-8FEB-AB323732C302Q47664013-4D4FBB60-7FA5-4426-B437-D508404F5870
P2860
Use of autoantibodies in breast cancer screening and diagnosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Use of autoantibodies in breast cancer screening and diagnosis.
@ast
Use of autoantibodies in breast cancer screening and diagnosis.
@en
type
label
Use of autoantibodies in breast cancer screening and diagnosis.
@ast
Use of autoantibodies in breast cancer screening and diagnosis.
@en
prefLabel
Use of autoantibodies in breast cancer screening and diagnosis.
@ast
Use of autoantibodies in breast cancer screening and diagnosis.
@en
P2093
P2860
P1476
Use of autoantibodies in breast cancer screening and diagnosis
@en
P2093
Andrea Murray
Anthony Barnes
Caroline J Chapman
Jayeta Chakrabarti
John F R Robertson
P2860
P304
P356
10.1586/14737140.6.8.1215
P577
2006-08-01T00:00:00Z